News
MLAB
125.71
+3.41%
4.15
Weekly Report: what happened at MLAB last week (0902-0906)?
Weekly Report · 5d ago
Mesa Laboratories: Statement of changes in beneficial ownership of securities
Press release · 09/06 16:30
AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?
NASDAQ · 09/04 13:15
Weekly Report: what happened at MLAB last week (0826-0830)?
Weekly Report · 09/02 09:25
Wells Fargo Initiates Coverage of Mesa Laboratories (MLAB) with Underweight Recommendation
NASDAQ · 08/29 05:50
Ex-Dividend Reminder: Mesa Laboratories, Perrigo and McKesson
NASDAQ · 08/28 15:35
Conestoga Capital Advisors Q2 2024 Commentary
Seeking Alpha · 08/28 11:05
Mesa Labs Initiated at Underweight by Wells Fargo
Dow Jones · 08/27 22:10
Surging Earnings Estimates Signal Upside for Mesa Labs (MLAB) Stock
NASDAQ · 08/26 16:20
Mesa Labs (MLAB) Moves to Strong Buy: Rationale Behind the Upgrade
NASDAQ · 08/26 16:00
New Strong Buy Stocks for August 26th
NASDAQ · 08/26 10:23
Weekly Report: what happened at MLAB last week (0819-0823)?
Weekly Report · 08/26 09:25
Small-cap and mid-cap Health Care has room to rally - Roth MKM
Seeking Alpha · 08/19 19:07
Mesa Laboratories: Statement of changes in beneficial ownership of securities
Press release · 08/19 16:14
Weekly Report: what happened at MLAB last week (0812-0816)?
Weekly Report · 08/19 09:23
Weekly Report: what happened at MLAB last week (0805-0809)?
Weekly Report · 08/12 09:23
Mesa Labs Is Maintained at Outperform by Evercore ISI Group
Dow Jones · 08/06 12:42
Mesa Labs Price Target Raised to $120.00/Share From $106.00 by Evercore ISI Group
Dow Jones · 08/06 12:42
Evercore ISI Group Maintains Outperform on Mesa Laboratories, Raises Price Target to $120
Benzinga · 08/06 12:31
More
Webull provides a variety of real-time MLAB stock news. You can receive the latest news about Mesa Laboratories through multiple platforms. This information may help you make smarter investment decisions.
About MLAB
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. Its segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. It also provides testing and laboratory services, mainly to the dental and pharmaceutical industries. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services quality control products. It has manufacturing operations in the United States and Europe.